{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:28:45Z","timestamp":1786786125078,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07171-1","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:16:04Z","timestamp":1783559764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Baseline immunonutritional status drives CAR T-cell efficacy, survival, and safety in R\/R lymphoma: validation of a pre-lymphodepletion PNI threshold"],"prefix":"10.1007","volume":"105","author":[{"given":"Na","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"7171_CR1","doi-asserted-by":"publisher","unstructured":"Shune L, Frigault MJ, Riedell PA (2025) CAR-T cell therapy in older adults with relapsed\/refractory LBCL: benefits and challenges. J Immunother Cancer 13(6). https:\/\/doi.org\/10.1136\/jitc-2024-009793","DOI":"10.1136\/jitc-2024-009793"},{"issue":"1","key":"7171_CR2","first-page":"77","volume":"30","author":"CA Jacobson","year":"2024","unstructured":"Jacobson CA, Munoz J, Sun F, Kanters S, Limbrick-Oldfield EH, Spooner C et al (2024) Real-World Outcomes with Chimeric Antigen Receptor T Cell Therapies in Large B Cell Lymphoma: A Systematic Review and Meta-Analysis. Transpl Cell Ther 30(1):77 e1- e15","journal-title":"Transpl Cell Ther"},{"issue":"19","key":"7171_CR3","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1182\/bloodadvances.2020002394","volume":"4","author":"FL Locke","year":"2020","unstructured":"Locke FL, Rossi JM, Neelapu SS, Jacobson CA, Miklos DB, Ghobadi A et al (2020) Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv 4(19):4898\u20134911","journal-title":"Blood Adv"},{"issue":"19","key":"7171_CR4","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1182\/blood.2020007445","volume":"137","author":"MD Jain","year":"2021","unstructured":"Jain MD, Zhao H, Wang X, Atkins R, Menges M, Reid K et al (2021) Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma. Blood 137(19):2621\u20132633","journal-title":"Blood"},{"issue":"1","key":"7171_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-018-0653-x","volume":"11","author":"D Liu","year":"2018","unstructured":"Liu D, Zhao J (2018) Cytokine release syndrome: grading, modeling, and new therapy. J Hematol Oncol 11(1):121","journal-title":"J Hematol Oncol"},{"issue":"4","key":"7171_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner RC, Sterner RM (2021) CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J 11(4):69","journal-title":"Blood Cancer J"},{"issue":"6","key":"7171_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1158\/2326-6066.CIR-22-0487","volume":"11","author":"K Rejeski","year":"2023","unstructured":"Rejeski K, Cordas Dos Santos DM, Parker NH, Bucklein VL, Winkelmann M, Jhaveri KS et al (2023) Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy. Cancer Immunol Res 11(6):707\u2013719","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"7171_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/2326-6066.CIR-23-0313","volume":"11","author":"MT Nawas","year":"2023","unstructured":"Nawas MT, Scordo M (2023) Linking Body Composition and Nutritional Status with CAR T-cell Efficacy. Cancer Immunol Res 11(6):704","journal-title":"Cancer Immunol Res"},{"key":"7171_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fonc.2019.00322","volume":"9","author":"X Xu","year":"2019","unstructured":"Xu X, Gnanaprakasam JNR, Sherman J, Wang R (2019) A Metabolism Toolbox for CAR T Therapy. Front Oncol 9:322","journal-title":"Front Oncol"},{"issue":"9","key":"7171_CR10","first-page":"1001","volume":"85","author":"T Onodera","year":"1984","unstructured":"Onodera T, Goseki N, Kosaki G (1984) [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi 85(9):1001\u20131005","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"1","key":"7171_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2217\/fon.09.136","volume":"6","author":"CS Roxburgh","year":"2010","unstructured":"Roxburgh CS, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6(1):149\u2013163","journal-title":"Future Oncol"},{"key":"7171_CR12","doi-asserted-by":"publisher","unstructured":"Almasaudi AS, Dolan RD, Edwards CA, McMillan DC (2020) Hypoalbuminemia reflects nutritional risk, body composition and systemic inflammation and is independently associated with survival in patients with colorectal cancer. Cancers (Basel) 12(7). https:\/\/doi.org\/10.3390\/cancers12071986","DOI":"10.3390\/cancers12071986"},{"issue":"6","key":"7171_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1600-0609.2008.01129.x","volume":"81","author":"Y Oki","year":"2008","unstructured":"Oki Y, Yamamoto K, Kato H, Kuwatsuka Y, Taji H, Kagami Y et al (2008) Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients\u2019 survival benefit from rituximab. Eur J Haematol 81(6):448\u2013453","journal-title":"Eur J Haematol"},{"issue":"8","key":"7171_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/dox020","volume":"30","author":"M Nakatani","year":"2017","unstructured":"Nakatani M, Migita K, Matsumoto S, Wakatsuki K, Ito M, Nakade H et al (2017) Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy. Dis Esophagus 30(8):1\u20137","journal-title":"Dis Esophagus"},{"issue":"7","key":"7171_CR15","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00268-017-4437-1","volume":"42","author":"N Hirahara","year":"2018","unstructured":"Hirahara N, Tajima Y, Fujii Y, Kaji S, Yamamoto T, Hyakudomi R et al (2018) Preoperative Prognostic Nutritional Index Predicts Long-Term Surgical Outcomes in Patients with Esophageal Squamous Cell Carcinoma. World J Surg 42(7):2199\u20132208","journal-title":"World J Surg"},{"issue":"8","key":"7171_CR16","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.ejso.2016.05.029","volume":"42","author":"Y Yang","year":"2016","unstructured":"Yang Y, Gao P, Song Y, Sun J, Chen X, Zhao J et al (2016) The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis. Eur J Surg Oncol 42(8):1176\u20131182","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"7171_CR17","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1007\/s13277-014-2973-y","volume":"36","author":"S Hong","year":"2015","unstructured":"Hong S, Zhou T, Fang W, Xue C, Hu Z, Qin T et al (2015) The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients. Tumour Biol 36(5):3389\u20133397","journal-title":"Tumour Biol"},{"key":"7171_CR18","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.2147\/JIR.S340822","volume":"14","author":"Z Shen","year":"2021","unstructured":"Shen Z, Wang F, He C, Li D, Nie S, Bian Z et al (2021) The Value of Prognostic Nutritional Index (PNI) on Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: A Multicenter Retrospective Study of HHLWG Based on Propensity Score Matched Analysis. J Inflamm Res 14:5513\u20135522","journal-title":"J Inflamm Res"},{"issue":"18","key":"7171_CR19","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.2217\/bmm-2019-0303","volume":"13","author":"C Mirili","year":"2019","unstructured":"Mirili C, Paydas S, Kapukaya TK, Yilmaz A (2019) Systemic immune-inflammation index predicting survival outcome in patients with classical Hodgkin lymphoma. Biomark Med 13(18):1565\u20131575","journal-title":"Biomark Med"},{"issue":"11\u201312","key":"7171_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00508-016-1077-7","volume":"129","author":"V Perisa","year":"2017","unstructured":"Perisa V, Zibar L, Knezovic A, Perisa I, Sincic-Petricevic J, Aurer I (2017) Prognostic nutritional index as a predictor of prognosis in patients with diffuse large B cell lymphoma. Wien Klin Wochenschr 129(11\u201312):411\u2013419","journal-title":"Wien Klin Wochenschr"},{"key":"7171_CR21","doi-asserted-by":"publisher","first-page":"106664","DOI":"10.1016\/j.leukres.2021.106664","volume":"110","author":"J He","year":"2021","unstructured":"He J, Yin H, Xia Y, Wu JZ, Liang JH, Zhu HY et al (2021) Prognostic nutritional index, a novel biomarker which predicts worse prognosis in diffuse large B cell lymphoma. Leuk Res 110:106664","journal-title":"Leuk Res"},{"key":"7171_CR22","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3389\/fonc.2020.00877","volume":"10","author":"N Yao","year":"2020","unstructured":"Yao N, Hou Q, Zhang S, Xiao H, Liang Y, Xu X et al (2020) Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer\/T Cell Lymphoma, Nasal Type. Front Oncol 10:877","journal-title":"Front Oncol"},{"issue":"3","key":"7171_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/hon.3124","volume":"41","author":"Z Shen","year":"2023","unstructured":"Shen Z, Zhang S, Chen X, Zhang Q, Jiao Y, Shi Y et al (2023) Prognostic value of prognostic nutritional index on extranodal natural killer\/T-cell lymphoma patients: A multicenter propensity score matched analysis of 1022 cases in Huaihai Lymphoma Working Group. Hematol Oncol 41(3):380\u2013388","journal-title":"Hematol Oncol"},{"issue":"3","key":"7171_CR24","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s12094-024-03687-y","volume":"27","author":"X Liu","year":"2025","unstructured":"Liu X, Duan Y, Wang Y, Zhang X, Lv H, Li Q et al (2025) Predictive value of prognostic nutritional index as prognostic biomarkers in patients with lymphoma: a systematic review and meta-analysis. Clin Transl Oncol 27(3):1274\u20131287","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"7171_CR25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL, Ghobadi A, Turtle CJ, Brudno JN et al (2019) ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells. Biol Blood Marrow Transpl 25(4):625\u2013638","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"7171_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1182\/blood-2014-05-577189","volume":"125","author":"LH Sehn","year":"2015","unstructured":"Sehn LH, Gascoyne RD (2015) Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. Blood 125(1):22\u201332","journal-title":"Blood"},{"issue":"8","key":"7171_CR27","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00277-014-2116-y","volume":"93","author":"A Carbone","year":"2014","unstructured":"Carbone A, Gloghini A, Kwong YL, Younes A (2014) Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy. Ann Hematol 93(8):1263\u20131277","journal-title":"Ann Hematol"},{"key":"7171_CR28","doi-asserted-by":"publisher","first-page":"1654407","DOI":"10.3389\/fnut.2025.1654407","volume":"12","author":"P Xu","year":"2025","unstructured":"Xu P, Liu Y, Wang Y, Feng Q, Zhang H, Cheng H et al (2025) Nutritional status indices on the prognosis of patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy. Front Nutr 12:1654407","journal-title":"Front Nutr"},{"issue":"15","key":"7171_CR29","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1182\/bloodadvances.2023012470","volume":"8","author":"M Mejia Saldarriaga","year":"2024","unstructured":"Mejia Saldarriaga M, Pan D, Unkenholz C, Mouhieddine TH, Velez-Hernandez JE, Engles K et al (2024) Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma. Blood Adv 8(15):3859\u20133869","journal-title":"Blood Adv"},{"key":"7171_CR30","doi-asserted-by":"publisher","first-page":"1155216","DOI":"10.3389\/fimmu.2023.1155216","volume":"14","author":"Y Lu","year":"2023","unstructured":"Lu Y, Zhu H, Liu Y, Wang Y, Sun Y, Cheng H et al (2023) Prognostic value of prelymphodepletion absolute lymphocyte counts in relapsed\/refractory diffuse large B-cell lymphoma patients treated with chimeric antigen receptor T cells. Front Immunol 14:1155216","journal-title":"Front Immunol"},{"issue":"1","key":"7171_CR31","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1186\/s12885-023-11540-8","volume":"23","author":"S Ding","year":"2023","unstructured":"Ding S, Chen R, Wang L, Zu C, Zhou X, Zhang J et al (2023) Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed\/refractory hematological malignancies after CAR-T cell therapy. BMC Cancer 23(1):1055","journal-title":"BMC Cancer"},{"issue":"10","key":"7171_CR32","first-page":"838","volume":"44","author":"XZ Xu","year":"2023","unstructured":"Xu XZ, Liu R, Zhao WH, Yang Y, Liu J, Zhang WG et al (2023) [Alteration and significance of serum lipid levels and nutritional status during BCMA-CAR-T-cell therapy in patients with refractory or relapsed multiple myeloma: a retrospective study based on LEGEND-2]. Zhonghua Xue Ye Xue Za Zhi 44(10):838\u2013844","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"1","key":"7171_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1182\/bloodadvances.2024014555","volume":"9","author":"YK Valtis","year":"2025","unstructured":"Valtis YK, Devlin S, Shouval R, Rejeski K, Corona M, De Luna A et al (2025) Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes. Blood Adv 9(1):151\u2013161","journal-title":"Blood Adv"},{"issue":"4","key":"7171_CR34","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1007\/s00520-021-06639-2","volume":"30","author":"S Ding","year":"2022","unstructured":"Ding S, Cai L, Jin A, Zhou X, Yan J, Wang L et al (2022) Nutritional status alterations after chimeric antigen receptor T cell therapy in patients with hematological malignancies: a retrospective study. Support Care Cancer 30(4):3321\u20133327","journal-title":"Support Care Cancer"},{"issue":"19","key":"7171_CR35","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1002\/cncr.34405","volume":"128","author":"S Ma","year":"2022","unstructured":"Ma S, Zhang B, Lu T, Li D, Li T, Shen Z et al (2022) Value of the prognostic nutritional index (PNI) in patients with newly diagnosed, CD5-positive diffuse large B-cell lymphoma: A multicenter retrospective study of the Huaihai Lymphoma Working Group. Cancer 128(19):3487\u20133494","journal-title":"Cancer"},{"key":"7171_CR36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12935-020-01535-x","volume":"20","author":"C Luan","year":"2020","unstructured":"Luan C, Wang F, Wei N, Chen B (2020) Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis. Cancer Cell Int 20:455","journal-title":"Cancer Cell Int"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07171-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07171-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07171-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:20:15Z","timestamp":1786785615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07171-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7171"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07171-1","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Committee of Beijing GoBroad HospitalApproval No.RP2025-033.approval date:June 25, 2025.and conducted according to the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"341"}}